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doi:10.1016/j.ejvs.2009.04.003Abstract Objective: To evaluate treatment of the small saphenous vein (SSV) by endovenous
laser ablation.
Study design: A cohort study, occlusion of the vein and safety of the procedure was analysed
prospectively.
Patients: 150 consecutive patients (169 limbs) were treated between August 2006 and January
2008 in an outpatient clinic setting. The average age was 57 years (range 23e87); 82% female;
31% had serious varicose disease (CEAP 3e6). Treated length averaged 23 cm (range 6e53 cm).
Methods: All patients underwent a standardised assessment comprising digital questionnaire,
physical examination and duplex ultrasonography. The SSV was cannulated percutaneously
under ultrasound control and perivascular local anaesthesia (tumescent) was injected. An
810 nm diode laser was used, delivering 70 J/cm. Three months post-treatment all patients
received a duplex ultrasound of the treated vessel.
Results: Complete occlusion of the SSV after 3 months was achieved in 98% of the cases. Two
patients (1.3%) had sural nerve paraesthesia. Six patients developed superficial thrombophle-
bitis. Serious complications did not occur.
Conclusions: Endovenous laser ablation for treating the incompetent small saphenous vein is
a safe, effective and technically feasible technique.
ª 2009 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.Introduction
Endovenous laser ablation (EVLA) for varicose veins is
a widely accepted form of treatment.1,2 Several studies591 691313; fax: þ31 591
.J. Hissink).
lsevier Ltd on behalf of Europeanhave shown that endovenous ablation of the Great
Saphenous Vein (GSV) achieves an outcome equivalent to
surgical treatment by sapheno-femoral ligation and
stripping.3e5
The aim of our study was to assess whether EVLA of the
small saphenous vein (SSV) can achieve the same results as
in the GSV. The main advantages are that the procedure is
minimally invasive, the entire vein is obliterated andSociety for Vascular Surgery.
200 L.C. Huisman et al.accuracy of treatment is high, due to the continuous duplex
visualisation of the vein during the procedure.
Surgical treatment of incompetence of the SSV usually
involves SPJ ligation. Stripping of the SSV is not recom-
mended in the Netherlands because of the risk of sural
nerve injury,6 yet there is very little data to support this
cautious approach.7
Even in experienced hands sapheno-popliteal ligation is
not always technically successful. This is mainly due to the
diverse anatomic anomalies of sapheno-popliteal junction
(SPJ) and its proximity to the tibial and sural nerves in the
popliteal space (see Fig. 1). Rashid et al. have shown that
ligation of the SPJ is not achieved in 30% of the cases, even if
the junction is marked pre-operatively under ultrasound
guidance.8 The incision made in the popliteal fossa is associ-
ated with wound healing problems and infection in 19e23% of
cases.9,10 In theNetherlands, sapheno-popliteal ligationalone
is recommended for the treatment of an incompetent SSV.6
Since conventional surgical treatment is associated with
these adverse factors, we performed a prospective cohort
study to analyse the safety and efficacy of EVLA in the SSV.
Materials and Methods
Study design
This cohort study included patients treated at the Centre
for Phlebology Emmen, a specialised outpatient clinic forFigure. 1 Endovenous laser procedure of the small saphe-
nous vein, showing the anatomical structures in proximity to
the vein, where the first half of the vein has been obliterated.varicose veins, between August 2006 and January 2008.
Following an interview using a standardised digital ques-
tionnaire and a physical examination, all patients under-
went duplex ultrasound scan of the affected leg. The
vascular surgeon, together with the dermatologist, decided
on the best treatment modality for the patient. The
severity of the venous insufficiency was graded following
the C part of the CEAP (Clinical, Etiology, Anatomy and
Pathophysiology) classification.11
Patientswith incompetenceof theSSVandclinical signsand
symptoms were treated in preference by endovenous laser
ablation. Thosewhopreferred general anaesthesia orwho had
suffered reported severe phlebitis in their medical history
(with evidence of intra-lumenal scars on ultrasound imaging)
were treated conventionally using surgical techniques.
Operative technique
The EVLA patients were treated in an outpatient setting.
The whole procedure was performed under ultrasound
guidance (Philips iU22 Ultrasound System, Philips Medical
Systems, The Netherlands) by the vascular lab technician.
Intra-lumenal access was achieved percutaneously using an
18 gauge needle at the most suitable distal point in the SSV.
Factors determining this point were: the most distal point
required to treat the incompetent segment of vein, the
point just distal of the last tributary vein, or a change in
diameter at which the distal part of the SSV was less than
3 mm in diameter.
A 5 Fr sheath was introduced over a standard J-wire. The
laser fibre was inserted through the sheath and the tip was
placed 2e3 cm from the SPJ. The main factors for deter-
mining this point were that the tip was placed beneath the
fascia, and at a safe distance from the SPJ. Taking into
consideration that the laser occludes at least 7 mm of the
vein proximal to the tip of the laser fibre. An 810 nm diode
laser (Delta 15 W, Diomed, MA, USA) was used with 14 W
continuous mode, delivering 70 J/cm.
The whole procedure was performed under local tumes-
cent anaesthesia (300 ml sodium chloride 0.9%, 20 ml xylo-
cain 1%/adrenalin 1:200.000, 10 ml sodium bicarbonate
8.4%). No additional treatment for varices was undertaken
contemporaneously, either by sclerotherapy or phlebectomy.
After treatment, all patients returned home with
35 mmHg compression stockings (Mediven Struva AG hip,
Medi, The Netherlands) for 72 h. Patients were advised to
walk regularly (at least 3 times daily 20 min) and prescribed
diclofenac (50 mg three times a day) for 10 days post-
operatively. Patients over 60 years of age or with symptoms
received also omeprazole (40 mg once daily).
If the patient had further incompetent saphenous veins,
these were treated by EVLA in the same session unless the
patient preferred otherwise.Follow-up
Six weeks after the procedure the patients were checked
by an independent observer (physician assistant, who was
not involved in the EVLA procedure) in the outpatient clinic
for any remaining ecchymosis, pain, remaining symptoms
and paraesthesia. This assessment allowed any further
Table 2 Reported series of endovenous laser ablation of
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for a future date, if required. Three months after the
procedure patients underwent duplex ultrasound scanning
to assess the degree of occlusion of the vein and presence
of thrombi in the deep venous system. Any occlusion less
than the complete treatment length was scored as partially
occluded.
All the data was collected prospectively in a Microsoft
Excel database that was also used for statistical purposes.
Results
All procedures were performed by three vascular surgeons
during an 18-month period. In total 169 limbs (150 patients)
were treated. In the same time frame 11 patients were
treated in the operating theatre under general anaesthesia
by sapheno-popliteal ligated and phlebectomies. Two
patients were not considered suitable for EVLA, because of
intra-lumenal scarring after an earlier episode of throm-
bophlebitis, the 9 other patients preferred to be treated
under general anaesthesia. At that time the operating
theatre did not meet safety requirements to perform
endovenous laser ablation, so they were all treated by the
conventional surgical method.
The mean age of the patients treated was 57 years (23e
87 years) and 82% were women. Twelve patients (7%) had
had previous sapheno-popliteal ligation for the manage-
ment of varicose veins. 31% had severe venous disease
(CEAP 3e6). Mean SSV diameter was 6.6 mm (3.2e
26.7 mm). Mean treated length was 23 cm (range 6e53 cm).
The upper limit in the range was an incompetent Giacomini
vein (see Table 1). 78 patients received concomitant
treatment of the GSV in the same leg at the same time. 20
Patients received treatment of the GSV in the contralateral
limb. One patient was treated for anterior accessory
saphenous vein reflux. 5 Patients had thrombophlebitis in
the SSV (all were treated successfully).
Following the post-operative review at 6 weeks, scle-
rotherapy of saphenous tributaries was performed in 56
patients and one patient underwent phlebectomy. After 3
months duplex ultrasound scanning was performed in 150
limbs (89%). 19 Legs were lost to follow-up: 1 patient had
died, 1 patient received underwent duplex ultrasound
scanning, but the report was lost, and 15 patients (17 legs)
did not attend for their appointment. This showed 148
completely occluded vessels (98%); 1 partially occludedTable 1 Demographics
NZ 169 limbs
Age (mean, range) 57 (23e87)
Female gender 138 (82%)
Limb (left/right) 86/83 (51%/49%)
Previous ligation/stripping 12 (7%)
CEAP classification (clinical)
Class 1 4 (2%)
Class 2 112 (66%)
Class 3-4 41 (24%)
Class 5-6 12 (7%)(0.7%) and 1 not occluded (0.7%). No deep venous throm-
bosis was seen. Two patients (1.3%) complained about
numbness of the lateral lower leg and foot (the sural
nerve); in one of these patients the paraesthesia was
completely resolved after two months.
Six patients (6 limbs) had superficial thrombophlebitis
which resolved spontaneously over time.
Discussion
Endovenous ablation by laser, radiofrequency or bipolar
diathermy is the minimally invasive alternatives for oblit-
erating the incompetent SSV.
Few case series on laser ablation of the SSV have been
published (see Table 2). Proebstle was the first to write
about treating the small saphenous vein with EVLA in 2003,
31 patients were treated, 2 patients (11%) had sural nerve
paraesthesia and occlusion after 6 months of 100%.12 The
second series was published by Ravi in 2006, 981 patients
including 101 SSVs, sural nerve damage was not mentioned,
of 37 SSVs the follow-up was 3 years with 84% occlusion.13
Theivacumar treated 68 SSVs with a follow-up of 6 months
and reported 100% occlusion and transient numbness of the
sural nerve in 4%.14 In 2007 Gibson describes a single patient
group of 187 patients (210 SSVss) treated by EVLA, in which
96% was occluded after 4 months, 3 patients (1.6%) with
numbness of the lateral malleolus.15
Park published the largest and most recent series (344
patients), 2% sural nerve paraesthesia was reported and an
occlusion rate of 94% after 12 months in 108 patients.16
Our study shows comparable results to the previous
literature. The use of ultrasound guidance throughout the
procedure led to a high initial success with an occlusion
rate after 3 months of 98%. Few complications were
encountered: superficial thrombophlebitis (6 patients, 3.6%
in our series) is self-limiting and paraesthesia of the sural
nerve (2 patients, 1.3% in our series). In one of the
paraesthesia patients the numbness resolved in two
months. The procedure appears safe even for the 12
patients who had previously been treated by sapheno-
popliteal junction ligation, none of whom experience any
complications. Wound complications are not an issue sincethe small saphenous vein
Legs in
follow-upa
Follow-up Occlusion Sural nerve
damage
Park16 2008 108 (390) 12 months 94% 2%
Gibson15 2007 120 (210) 4 months 96% 1.6%
Theivacumar14
2006
48 (68) 6 months 100% 4.4%
Ravi13 2006 37 (101) 3 years 84% Not
mentioned
Proebstle12
2003
37 (41) 6 months 100% 11%
Our results 150 (169) 3 months 98% 1.3%
a Number mentioned is the total of legs in follow-up; the
number between brackets is the initial number of treated limbs.
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infection.
In the recent literature on endovenous laser ablation of
the SSV the frequency of sural nerve paraesthesia was less
than 2%.15,16
Very few publications in the recent literature have been
published on the results and complication rate of the
present surgical standard: ligation of the sapheno-popliteal
junction.17 In one study assessing technical success of
surgical of the junction, good or satisfactory results were
achieved in only 59% of the cases, even if the insertion of
the SSV in the popliteal vein was marked pre-operatively
with ultrasound imaging.8 The frequency of sural nerve
damage after surgical ligation of the SPJ and stripping of
the SSV are highly variable, ranging from 0% to 21%.7
In conclusion, published data show that open surgical
treatment of the SSV has a mediocre initial technical
success, judged by duplex ultrasonography. EVLA of the SSV
shows a high initial success rate. The main advantages are
accuracy of treatment attributable to duplex guidance
during the procedure and obliterating the entire vein
instead of just dividing the sapheno-popliteal junction.
Minimal post-operative morbidity was encountered since
there was no requirement for an incision in the popliteal
fossa. Our series show that endovenous laser ablation of the
SSV is a safe, effective and technically feasible technique.
At present surgery is the recommended treatment of
reflux of the SSV in the Netherlands. Only clinical series of
endovenous laser ablation of the small saphenous vein have
been published thus far, with promising results. A rando-
mised trial, comparing surgical treatment with endovenous
laser ablation with at least two year follow-up, should be
performed to assess the relative efficacy and complications
of these treatments.
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